We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+27.12%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$23.1B
AUM Growth
+$3.93B
Cap. Flow
-$364M
Cap. Flow %
-1.58%
Top 10 Hldgs %
44.28%
Holding
88
New
24
Increased
15
Reduced
29
Closed
16

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$980M
2
AMZN icon
Amazon
AMZN
+$645M
3
JD icon
JD.com
JD
+$536M
4
BSX icon
Boston Scientific
BSX
+$481M
5
LOW icon
Lowe's Companies
LOW
+$429M

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Consumer Discretionary 19.72%
3 Technology 19.48%
4 Financials 14.6%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COO icon
51
Cooper Companies
COO
$15B
$98M 0.42%
1,382,092
-365,852
-21% -$27.1M
NVST icon
52
Envista
NVST
$4.58B
$95.4M 0.41%
+4,524,346
New +$84.8M
AVTR icon
53
Avantor
AVTR
$9.31B
$93.1M 0.4%
5,475,379
-4,575,459
-46% -$74.5M
EG icon
54
Everest Group
EG
$14B
$86.2M 0.37%
+418,223
New +$81.4M
HZNP
55
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$81.8M 0.35%
1,471,419
-519,851
-26% -$22.2M
CME icon
56
CME Group
CME
$93.2B
$78.5M 0.34%
482,679
-1,219,294
-72% -$219M
TJX icon
57
TJX Companies
TJX
$172B
$76.8M 0.33%
+1,519,986
New +$76.3M
PVH icon
58
PVH
PVH
$3.91B
$73.2M 0.32%
+1,522,984
New +$71M
MELI icon
59
Mercado Libre
MELI
$98.4B
$68.4M 0.3%
69,344
-319,941
-82% -$240M
BMY.RT
60
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$67.9M 0.29%
18,968,019
-671,182
-3% -$2.42M
FWONK icon
61
Liberty Media Series C
FWONK
$25.7B
$61M 0.26%
1,989,456
CHNG
62
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$48.5M 0.21%
4,326,999
-8,450,240
-66% -$94.9M
VIE
63
DELISTED
Viela Bio, Inc. Common Stock
VIE
$45.4M 0.2%
1,049,000
-201,000
-16% -$9.1M
VAR
64
DELISTED
Varian Medical Systems, Inc.
VAR
$44.8M 0.19%
365,827
-501,283
-58% -$58.1M
V icon
65
Visa
V
$677B
$31.9M 0.14%
164,889
-265,220
-62% -$48.5M
MNTA
66
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$31.5M 0.14%
+946,220
New +$30.1M
GMAB icon
67
Genmab
GMAB
$19.2B
$19.5M 0.08%
575,086
-265,899
-32% -$7.25M
API
68
Agora
API
$395M
$17.7M 0.08%
+400,000
New +$18.9M
EDIT icon
69
Editas Medicine
EDIT
$453M
$12.2M 0.05%
413,000
-99,179
-19% -$2.59M
QURE icon
70
uniQure
QURE
$3.12B
$2.81M 0.01%
+62,396
New +$3.68M
ATYR
71
aTyr Pharma
ATYR
$52.4M
$2.61M 0.01%
587,444
TMUSR
72
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$302K ﹤0.01%
+1,799,550
New +$505K
A icon
73
Agilent Technologies
A
$42.2B
-2,789,478
Closed -$200M
AJG icon
74
Arthur J. Gallagher & Co
AJG
$65B
-1,158,751
Closed -$94.5M
BMRN icon
75
BioMarin Pharmaceuticals
BMRN
$13.5B
-1,453,625
Closed -$123M

Similar funds

Viking Global Investors's Q2 2020 Portfolio in Review

As of Q2 2020, Viking Global Investors held 88 positions worth $23.1B, up 20% from $19.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Viking Global Investors's Q2 2020 filing shows 24 new, 15 increased, 29 reduced and 16 closed positions. Its largest new stake was Thermo Fisher Scientific: 1,734,144 shares worth $628M. The largest sale was Netflix, an estimated $980M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Viking Global Investors's largest Q2 2020 buy was Thermo Fisher Scientific: 1,734,144 shares worth $628M.
  • Viking Global Investors added most to American Express in Q2 2020, an estimated $609M increase.
  • Viking Global Investors's biggest Q2 2020 reduction was Netflix, cutting an estimated $980M.
  • Viking Global Investors fully exited Elevance Health in Q2 2020, selling an estimated $411M.
  • Viking Global Investors's ten largest holdings make up 44% of its $23.1B portfolio in Q2 2020.
  • Viking Global Investors opened 24 new positions and closed 16 in Q2 2020.
  • Viking Global Investors's portfolio value rose 20% quarter-over-quarter to $23.1B.

Based on Viking Global Investors's 13F filing for Q2 2020, filed 7 Aug 2020.